Kathleen Skarvan - Nov 18, 2024 Form 4 Insider Report for Electromed, Inc. (ELMD)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
ELMD
Transactions as of
Nov 18, 2024
Transactions value $
-$4,201,350
Form type
4
Date filed
11/20/2024, 04:48 PM
Previous filing
Jan 29, 2024
Next filing
Dec 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELMD Common Stock Sale -$1.2M -42.5K -29.19% $28.16 103K Nov 18, 2024 Direct F1, F2
transaction ELMD Common Stock Sale -$1.41M -50.6K -49.13% $27.92 52.4K Nov 19, 2024 Direct F2, F3
transaction ELMD Common Stock Sale -$1.59M -56.9K -66.27% $27.97 29K Nov 19, 2024 By Trust F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 45,453 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on November 18, 2024 with purchase prices ranging from $28.00 to $28.8919 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 All sales of shares reported are part of a diversification of a portion of the reporting person's securities portfolio and individual financial and retirement planning.
F3 Reflects the weighted average price of 50,602 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on November 19, 2024 with purchase prices ranging from $27.7556 to $28.3137 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects the weighted average price of 56,945 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on November 19, 2024 with purchase prices ranging from $27.701 to $28.3121 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.